Anticancer agent 164
Modify Date: 2024-01-26 18:34:13
Anticancer agent 164 structure
|
Common Name | Anticancer agent 164 | ||
|---|---|---|---|---|
| CAS Number | 2235393-30-1 | Molecular Weight | 540.58 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H23F3N8O2S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Anticancer agent 164CML-IN-1 (compound 7) is a potent anticancer agent. CML-IN-1 displays very good induced-apoptosis effect for human chronic myeloid leukemia (CML) cell line K562. CML-IN-1 exerts its effect via a significantly reduced protein phosphorylation of PI3K/Akt signal pathway. CML-IN-1 (compound 4) also inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer[1][2]. |
| Name | Anticancer agent 164 |
|---|
| Description | CML-IN-1 (compound 7) is a potent anticancer agent. CML-IN-1 displays very good induced-apoptosis effect for human chronic myeloid leukemia (CML) cell line K562. CML-IN-1 exerts its effect via a significantly reduced protein phosphorylation of PI3K/Akt signal pathway. CML-IN-1 (compound 4) also inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C21H23F3N8O2S2 |
|---|---|
| Molecular Weight | 540.58 |